Pharmacokinetic and Biopharmaceutic Aspects of Once Daily Treatment with Metoprolol CR/ZOK: A Review Article
Authors:
- 1 February 1990
- journal article
- review article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 30 (S2) , S2-S16
Abstract
In the development of a new controlled release preparation and its subsequent assessment there are a number of factors that need to be considered both related to the drug itself and to the pharmaceutical preparation. This review describes the biopharmaceutical and pharmacokinetic properties of metoprolol CR/ZOK, a recently introduced formulation of a widely used beta1‐selective adrenoceptor antagonist intended for once daily usage.The metoprolol CR/ZOK preparation provides reproducible dissolution and absorption properties resulting in stable plasma concentrations with minimum fluctuations over a 24‐hour dosage interval. This has been shown in extensive studies comprising over 200 healthy volunteers. Considerations for a new drug preparation such as bioavailability and variability in relation to a standard treatment and the clinical significance of taking the drug with food and in increasing doses, are potential concerns that do not seem to be a problem for the therapeutic use of metoprolol CR/ZOK. Furthermore, the pharmacokinetic data achieved in young healthy subjects appear to be relevant for the treatment of patients, as shown by the consistent plasma concentration profiles obtained in elderly and in hypertensive patients.Keywords
This publication has 46 references indexed in Scilit:
- Pharmacokinetic and Pharmacodynamic Comparison of Metoprolol CR/ZOK Once Daily with Conventional Tablets Once Daily and in Divided DosesThe Journal of Clinical Pharmacology, 1990
- Pharmacokinetic and Pharmacodynamic Evaluation of Metoprolol Controlled Release (CR/ZOK) 50 mg in Young SubjectsThe Journal of Clinical Pharmacology, 1990
- Food Interactions with Sustained-Release Theophylline Preparations1Clinical Pharmacokinetics, 1989
- Furosemide pharmacokinetics and pharmacodynamics in health and disease—An updateJournal of Pharmacokinetics and Biopharmaceutics, 1989
- MetoprololDrugs, 1986
- The Polymorphic Oxidation of ??-Adrenoceptor AntagonistsClinical Pharmacokinetics, 1986
- Bioavailability of metoprolol in young adults and the elderly, with additional studies on the effects of metoclopramide and probanthineEuropean Journal of Clinical Pharmacology, 1983
- Pharmacokinetics of Metoprolol in Patients with Hepatic CirrhosisClinical Pharmacokinetics, 1981
- Pharmacokinetic and Pharmacodynamic Properties of Metoprolol in Patients with Impaired Renal FunctionClinical Pharmacokinetics, 1980
- Pharmacokinetic studies on the selectiveβ 1-receptor antagonist metoprolol in manJournal of Pharmacokinetics and Biopharmaceutics, 1974